There were 458 press releases posted in the last 24 hours and 441,892 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image